A motivational post that lumps peptides in with sleep rings, cortisol worries and perfect diets as minor stuff. Light on substance.
Recap by typeshit. Post by @mackinprof on Instagram.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
The piece recaps Phase 3 weight loss of up to 28.3% and notes TRIUMPH-3 didn't show fewer major heart events. Lilly aims to file in early 2027.
Quartz reports the benefit covers the two drugs for Type 2 diabetes, while many other large employers are cutting back on drug coverage.
Loading…